
Cabergoline is an ergot derivative indicated for the treatment of hyperprolactinemic disorders in adults, whether idiopathic or caused by pituitary adenomas.
Usage Limitation: Avoid using cabergoline to suppress or terminate physiological lactation after childbirth, due to the risk of serious adverse reactions.
FDA,2025.04

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: